BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia. N Engl J Med 1995;332:1065-9. [DOI: 10.1056/nejm199504203321604] [Cited by in Crossref: 297] [Cited by in F6Publishing: 94] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Shu L, Touzjian N, Nan D, Kushner N, Strong AJ, Zeping W, Zhaohui G, Lu Y. Recombinant hepatitis B large surface antigen, successfully produced in Escherichia coli, stimulates T-cell response in mice. Vaccine 2006;24:4409-16. [PMID: 16574283 DOI: 10.1016/j.vaccine.2006.02.048] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Invernizzi P. Human leukocyte antigen in primary biliary cirrhosis: an old story now reviving. Hepatology. 2011;54:714-723. [PMID: 21563204 DOI: 10.1002/hep.24414] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
3 An P, Winkler C, Guan L, O’Brien SJ, Zeng Z. A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese. J Infect Dis. 2011;203:943-947. [PMID: 21402545 DOI: 10.1093/infdis/jiq154] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
4 Zang GQ, Xi M, Feng ML, Ji Y, Yu YS, Tang ZH. Curative effects of interferon-α and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B. World J Gastroenterol 2004; 10(14): 2116-2118 [PMID: 15237447 DOI: 10.3748/wjg.v10.i14.2116] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
5 Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut. 2004;53:599-608. [PMID: 15016758 DOI: 10.1136/gut.2003.031732] [Cited by in Crossref: 98] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
6 Zhao Y, Zhu R, Tian D, Liu X. Genetic polymorphisms in Guillain-Barré Syndrome: A field synopsis and systematic meta-analysis. Autoimmun Rev 2020;19:102665. [PMID: 32949724 DOI: 10.1016/j.autrev.2020.102665] [Reference Citation Analysis]
7 He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 2006; 12(30): 4788-4793 [PMID: 16937459 DOI: 10.3748/wjg.v12.i30.4788] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
8 Yang ZT, Zhang XX, Kong XF, Zhang DH, Zhang SY, Jiang JH, Gong QM, Jin GD, Lu ZM. Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients. World J Gastroenterol 2008; 14(35): 5454-5460 [PMID: 18803359 DOI: 10.3748/wjg.14.5454] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
9 Cao T, Meuleman P, Desombere I, Sällberg M, Leroux-Roels G. In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model. J Virol. 2001;75:11449-11456. [PMID: 11689626 DOI: 10.1128/JVI.75.23.11449-11456.2001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
10 Utsunomiya T, Okamoto M, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Aishima S, Yoshikawa Y, Hanai T, Inoue H, Barnard GF, Mori M. A specific gene-expression signature quantifies the degree of hepatic fibrosis in patients with chronic liver disease. World J Gastroenterol 2007; 13(3): 383-390 [PMID: 17230606 DOI: 10.3748/wjg.v13.i3.383] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012;12:320-325. [PMID: 22783343 DOI: 10.5812/hepatmon.6094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
12 Chou HH, Chien WH, Wu LL, Cheng CH, Chung CH, Horng JH, Ni YH, Tseng HT, Wu D, Lu X, Wang HY, Chen PJ, Chen DS. Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci USA. 2015;112:2175-2180. [PMID: 25646429 DOI: 10.1073/pnas.1424775112] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 15.7] [Reference Citation Analysis]
13 Wright M, Goldin R, Hellier S, Knapp S, Frodsham A, Hennig B, Hill A, Apple R, Cheng S, Thomas H. Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut. 2003;52:1206-1210. [PMID: 12865283 DOI: 10.1136/gut.52.8.1206] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 5.2] [Reference Citation Analysis]
14 Oliver MK, Telfer S, Piertney SB. Major histocompatibility complex (MHC) heterozygote superiority to natural multi-parasite infections in the water vole (Arvicola terrestris). Proc Biol Sci 2009;276:1119-28. [PMID: 19129114 DOI: 10.1098/rspb.2008.1525] [Cited by in Crossref: 126] [Cited by in F6Publishing: 115] [Article Influence: 9.7] [Reference Citation Analysis]
15 Cui JJ, Zeng Z, Tian GB, Tian D, Lu HY. Advance in genetic factors influencing hepatitis B virus infection. Shijie Huaren Xiaohua Zazhi 2007; 15(11): 1246-1251 [DOI: 10.11569/wcjd.v15.i11.1246] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Zeng Z, Guan L, An P, Sun S, O’Brien SJ, Winkler CA. A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis. 2008;8:1. [PMID: 18171470 DOI: 10.1186/1471-2334-8-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
17 Zhang G, Wang W, Li S, Yang H, Zhang M, Zhang P, Wen Y, Wu A, Yang L, Zhou B, Chen X. IL6 gene allele-specific C/EBPα-binding activity affects the development of HBV infection through modulation of Th17/Treg balance. Genes Immun 2015;16:528-35. [PMID: 26447433 DOI: 10.1038/gene.2015.40] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Singh R, Kaul R, Kaul A, Khan K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J Gastroenterol 2007; 13(12): 1770-1787 [PMID: 17465466 DOI: 10.3748/wjg.v13.i12.1770] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 135] [Article Influence: 9.2] [Reference Citation Analysis]
19 Knapp LA, Innocent SH. Molecules and mating: positive selection and reproductive behaviour in primates. Adv Exp Med Biol 2012;739:218-36. [PMID: 22399405 DOI: 10.1007/978-1-4614-1704-0_14] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: A meta-analysis. World J Gastroenterol 2012; 18(24): 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
21 Thursz M. Basis of HBV persistence and new treatment options. Hepatol Int. 2014;8 Suppl 2:486-491. [PMID: 26201329 DOI: 10.1007/s12072-013-9504-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Abbott W, Gane E, Winship I, Munn S, Tukuitonga C. Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 2007;59:187-95. [PMID: 17211638 DOI: 10.1007/s00251-006-0184-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
23 Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, Lee KW. Human leukocyte antigen class II association with spontaneous recovery from hepatitis B virus infection in Koreans: analysis at the haplotype level. J Korean Med Sci. 2008;23:838-844. [PMID: 18955791 DOI: 10.3346/jkms.2008.23.5.838] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
24 Joshita S, Umemura T, Tanaka E, Ota M. Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis. J Immunol Res. 2017;2017:3073504. [PMID: 28255561 DOI: 10.1155/2017/3073504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
25 Lenz TL, Wells K, Pfeiffer M, Sommer S. Diverse MHC IIB allele repertoire increases parasite resistance and body condition in the Long-tailed giant rat (Leopoldamys sabanus). BMC Evol Biol 2009;9:269. [PMID: 19930637 DOI: 10.1186/1471-2148-9-269] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
26 Mascheretti S, Hinrichsen H, Ross S, Buggisch P, Hampe J, Foelsch UR, Schreiber S. Genetic variants in the CCR gene cluster and spontaneous viral elimination in hepatitis C-infected patients. Clin Exp Immunol. 2004;136:328-333. [PMID: 15086398 DOI: 10.1111/j.1365-2249.2004.02444.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
27 Malhotra U, Holte S, Dutta S, Berrey MM, Delpit E, Koelle DM, Sette A, Corey L, McElrath MJ. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment. J Clin Invest 2001;107:505-17. [PMID: 11181650 DOI: 10.1172/JCI11275] [Cited by in Crossref: 95] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
28 Tillmann HL, Chen DF, Trautwein C, Kliem V, Grundey A, Berning-Haag A, Böker K, Kubicka S, Pastucha L, Stangel W, Manns MP. Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut 2001;48:714-8. [PMID: 11302974 DOI: 10.1136/gut.48.5.714] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 2.0] [Reference Citation Analysis]
29 Davenport MP, Quinn CL, Valsasnini P, Sinigaglia F, Hill AV, Bell JI. Analysis of peptide-binding motifs for two disease associated HLA-DR13 alleles using an M13 phage display library. Immunology 1996;88:482-6. [PMID: 8881746 DOI: 10.1046/j.1365-2567.1996.d01-693.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
30 Xu T, Zhu A, Sun M, Lv J, Qian Z, Wang X, Wang T, Wang H. Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. Oncotarget 2018;9:96-109. [PMID: 29416599 DOI: 10.18632/oncotarget.22941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Gheuens S, Fellay J, Goldstein DB, Koralnik IJ. Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy. J Neurovirol 2010;16:41-7. [PMID: 20105104 DOI: 10.3109/13550280903552438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
32 Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP, Tian Y, Li RC, Li Z, Zhu X. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One. 2011;6:e17608. [PMID: 21408128 DOI: 10.1371/journal.pone.0017608] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 5.0] [Reference Citation Analysis]
33 Li Y, Si L, Zhai Y, Hu Y, Hu Z, Bei JX, Xie B, Ren Q, Cao P, Yang F, Song Q, Bao Z, Zhang H, Han Y, Wang Z, Chen X, Xia X, Yan H, Wang R, Zhang Y, Gao C, Meng J, Tu X, Liang X, Cui Y, Liu Y, Wu X, Li Z, Wang H, Hu B, He M, Gao Z, Xu X, Ji H, Yu C, Sun Y, Xing B, Yang X, Tan A, Wu C, Jia W, Li S, Zeng YX, Shen H, He F, Mo Z, Zhou G. Genome-wide association study identifies 8p21.3 associated with persistent hepatitis B virus infection among Chinese. Nat Commun. 2016;7:11664. [PMID: 27244555 DOI: 10.1038/ncomms11664] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
34 Qutob N, Balloux F, Raj T, Liu H, Marion de Procé S, Trowsdale J, Manica A. Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics 2012;64:165-75. [PMID: 21947542 DOI: 10.1007/s00251-011-0576-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kapoor R, Kottilil S. Strategies to eliminate HBV infection. Future Virol 2014;9:565-85. [PMID: 25309617 DOI: 10.2217/fvl.14.36] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
36 Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083-7. [PMID: 14581545 DOI: 10.1128/jvi.77.22.12083-12087.2003] [Cited by in Crossref: 95] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
37 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(6): 760-762 [DOI: 10.11569/wcjd.v11.i6.760] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ferre AL, Hunt PW, McConnell DH, Morris MM, Garcia JC, Pollard RB, Yee HF Jr, Martin JN, Deeks SG, Shacklett BL. HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol 2010;84:11020-9. [PMID: 20719952 DOI: 10.1128/JVI.00980-10] [Cited by in Crossref: 75] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
39 Zhi-ming L, Yu-lian J, Zhao-lei F, Chun-xiao W, Zhen-fang D, Bing-chang Z, Yue-ran Z. Polymorphisms of killer cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. Croat Med J 2007;48:800-6. [PMID: 18074414 DOI: 10.3325/cmj.2007.6.800] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
40 Chen SH, Wu HL, Kao JH, Hwang LH. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors. PLoS One. 2012;7:e36984. [PMID: 22615863 DOI: 10.1371/journal.pone.0036984] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
41 Wang L, Zou ZQ, Wang K. Clinical Relevance of HLA Gene Variants in HBV Infection. J Immunol Res. 2016;2016:9069375. [PMID: 27243039 DOI: 10.1155/2016/9069375] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
42 Cheong JY, Cho SW, Lim SK, Shin DH, Yoon SK, Lee JE, Hahm KB, Kim JH. Lack of association between hepatitis B virus infection and polymorphism of mannose-binding lectin gene in Korean population. J Korean Med Sci. 2005;20:65-69. [PMID: 15716605 DOI: 10.3346/jkms.2005.20.1.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
43 Joshita S, Umemura T, Tanaka E, Ota M. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis. Clin J Gastroenterol 2018;11:11-8. [PMID: 29159718 DOI: 10.1007/s12328-017-0799-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
44 Bexfield NH, Watson PJ, Aguirre-Hernandez J, Sargan DR, Tiley L, Heeney JL, Kennedy LJ. DLA class II alleles and haplotypes are associated with risk for and protection from chronic hepatitis in the English Springer spaniel. PLoS One 2012;7:e42584. [PMID: 22870335 DOI: 10.1371/journal.pone.0042584] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
45 Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ, Hu YX, Mu M, Wang B. Quantitative assessment of common genetic variations in HLA-DP with hepatitis B virus infection, clearance and hepatocellular carcinoma development. Sci Rep. 2015;5:14933. [PMID: 26462556 DOI: 10.1038/srep14933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
46 Batey RG, Bollipo SJ. Hepatitis B. Drug Alcohol Rev 1996;15:289-305. [PMID: 16203384 DOI: 10.1080/09595239600186031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
47 Tandoh KZ, Kusi KA, Archampong TN, Boamah I, Quaye O. Hepatitis B infection outcome is associated with novel human leukocyte antigen variants in Ghanaian cohort. Exp Biol Med (Maywood) 2020;245:815-22. [PMID: 32349537 DOI: 10.1177/1535370220921118] [Reference Citation Analysis]
48 Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Ha LD, Ban VV, Hoa BK, Hang NT, Hijikata M, Sakurada S, Satake M, Tokunaga K, Sasazuki T, Quy T. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol. 2009;70:527-531. [PMID: 19445991 DOI: 10.1016/j.humimm.2009.05.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
49 Kovacs AAZ, Kono N, Wang CH, Wang D, Frederick T, Operskalski E, Tien PC, French AL, Minkoff H, Kassaye S, T Golub E, Aouizerat BE, Kuniholm MH, Millstein J. Association of HLA Genotype With T-Cell Activation in Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus-Coinfected Women. J Infect Dis 2020;221:1156-66. [PMID: 31802115 DOI: 10.1093/infdis/jiz589] [Reference Citation Analysis]
50 Akcay IM, Katrinli S, Ozdil K, Doganay GD, Doganay L. Host genetic factors affecting hepatitis B infection outcomes: Insights from genome-wide association studies. World J Gastroenterol 2018; 24(30): 3347-3360 [PMID: 30122875 DOI: 10.3748/wjg.v24.i30.3347] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
51 Höhler T, Kruger A, Gerken G, Schneider PM, Meyer zum Büschenefelde KH, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998;111:579-82. [PMID: 9528902 DOI: 10.1046/j.1365-2249.1998.00534.x] [Cited by in Crossref: 149] [Cited by in F6Publishing: 145] [Article Influence: 6.2] [Reference Citation Analysis]
52 Jiang H, Cao F, Cao H, Rao Q, Yang Y. Associations of human leukocyte antigen and interleukin-18 gene polymorphisms with viral load in patients with hepatitis B infection. Medicine (Baltimore) 2018;97:e11249. [PMID: 30045250 DOI: 10.1097/MD.0000000000011249] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS One. 2012;7:e39175. [PMID: 22737229 DOI: 10.1371/journal.pone.0039175] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 10.5] [Reference Citation Analysis]
54 Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. PLoS One. 2013;8:e66920. [PMID: 23825586 DOI: 10.1371/journal.pone.0066920] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
55 Li X, Zhou TC, Wu CH, Tao LL, Bi R, Chen LJ, Deng DY, Liu C, Otecko NO, Tang Y, Lai X, Zhang L, Wei J. Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China. Sci Rep 2018;8:869. [PMID: 29343698 DOI: 10.1038/s41598-018-19184-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Karayiannis P, Alexopoulou A, Hadziyannis S, Thursz M, Watts R, Seito S, Thomas HC. Fulminant hepatitis associated with hepatitis B virus e antigen–negative infection: Importance of host factors. Hepatology 1995;22:1628-34. [DOI: 10.1002/hep.1840220603] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
57 Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, Almasio P, Rosina F, Marzioni M, Fabris L. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. Hepatology. 2008;48:1906-1912. [PMID: 19003916 DOI: 10.1002/hep.22567] [Cited by in Crossref: 90] [Cited by in F6Publishing: 81] [Article Influence: 6.9] [Reference Citation Analysis]
58 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
59 Toukan AU. Hepatitis B in the Middle East: aspects of epidemiology and liver disease after infection. Gut 1996;38 Suppl 2:S2-4. [PMID: 8786048 DOI: 10.1136/gut.38.suppl_2.s2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
60 Lee SH, Dimock K, Gray DA, Beauchemin N, Holmes KV, Belouchi M, Realson J, Vidal SM. Maneuvering for advantage: the genetics of mouse susceptibility to virus infection. Trends Genet 2003;19:447-57. [PMID: 12902163 DOI: 10.1016/S0168-9525(03)00172-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
61 Ward H, Tang L, Poonia B, Kottilil S. Treatment of hepatitis B virus: an update. Future Microbiol. 2016;11:1581-1597. [PMID: 27855500 DOI: 10.2217/fmb-2016-0128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
62 Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Grüner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin Exp Immunol. 1998;113:244-251. [PMID: 9717974 DOI: 10.1046/j.1365-2249.1998.00665.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 2.5] [Reference Citation Analysis]
63 Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41:591-595. [PMID: 19349983 DOI: 10.1038/ng.348] [Cited by in Crossref: 375] [Cited by in F6Publishing: 363] [Article Influence: 28.8] [Reference Citation Analysis]
64 Selva KJ, van de Sandt CE, Lemke MM, Lee CY, Shoffner SK, Chua BY, Davis SK, Nguyen THO, Rowntree LC, Hensen L, Koutsakos M, Wong CY, Mordant F, Jackson DC, Flanagan KL, Crowe J, Tosif S, Neeland MR, Sutton P, Licciardi PV, Crawford NW, Cheng AC, Doolan DL, Amanat F, Krammer F, Chappell K, Modhiran N, Watterson D, Young P, Lee WS, Wines BD, Mark Hogarth P, Esterbauer R, Kelly HG, Tan HX, Juno JA, Wheatley AK, Kent SJ, Arnold KB, Kedzierska K, Chung AW. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun 2021;12:2037. [PMID: 33795692 DOI: 10.1038/s41467-021-22236-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 23.0] [Reference Citation Analysis]
65 Manczinger M, Boross G, Kemény L, Müller V, Lenz TL, Papp B, Pál C. Pathogen diversity drives the evolution of generalist MHC-II alleles in human populations. PLoS Biol 2019;17:e3000131. [PMID: 30703088 DOI: 10.1371/journal.pbio.3000131] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 9.7] [Reference Citation Analysis]
66 Khakoo SI, Ling R, Scott I, Dodi AI, Harrison TJ, Dusheiko GM, Madrigal JA. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals. Gut 2000;47:137-43. [PMID: 10861276 DOI: 10.1136/gut.47.1.137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
67 Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, O’Brien SJ, Karacki P, Astemborski J, Carrington M. HLA-Cw*04 and hepatitis C virus persistence. J Virol. 2002;76:4792-4797. [PMID: 11967296 DOI: 10.1128/jvi.76.10.4792-4797.2002] [Cited by in Crossref: 130] [Cited by in F6Publishing: 60] [Article Influence: 6.5] [Reference Citation Analysis]
68 Kwiatkowski D. Science, medicine, and the future: susceptibility to infection. BMJ 2000;321:1061-5. [PMID: 11053181 DOI: 10.1136/bmj.321.7268.1061] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
69 Choga WT, Anderson M, Zumbika E, Phinius BB, Mbangiwa T, Bhebhe LN, Baruti K, Kimathi PO, Seatla KK, Musonda RM, Bell TG, Moyo S, Blackard JT, Gaseitsiwe S. In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana. Viruses 2020;12:E731. [PMID: 32640609 DOI: 10.3390/v12070731] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
70 Li J, Yang D, He Y, Wang M, Wen Z, Liu L, Yao J, Matsuda K, Nakamura Y, Yu J. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One. 2011;6:e24221. [PMID: 21904616 DOI: 10.1371/journal.pone.0024221] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
71 Cramp ME, Carucci P, Rossol S, Chokshi S, Maertens G, Williams R, Naoumov NV. Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 1999;44:424-9. [PMID: 10026332 DOI: 10.1136/gut.44.3.424] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
72 Pierini F, Lenz TL. Divergent Allele Advantage at Human MHC Genes: Signatures of Past and Ongoing Selection. Mol Biol Evol 2018;35:2145-58. [PMID: 29893875 DOI: 10.1093/molbev/msy116] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 32.0] [Reference Citation Analysis]
73 Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003;77:12083-12087. [PMID: 14581545 DOI: 10.1128/jvi.77] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
74 Zhang SY, Li D, Gu HX, Li XK, Jin X, Liu W, Du B, Lu B. Analysis of the polymorphism of human leukocyte antigen (HLA) class and class alleles in HBV infection. Shijie Huaren Xiaohua Zazhi 2006; 14(10): 963-968 [DOI: 10.11569/wcjd.v14.i10.963] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Cheong JY, Cho SW, Lee JA, Lee KJ, Wang HJ, Lee JE, Kim JH. Matrix metalloproteinase-3 genotypes influence recovery from hepatitis B virus infection. J Korean Med Sci. 2008;23:61-65. [PMID: 18303200 DOI: 10.3346/jkms.2008.23.1.61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
76 Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells. Front Immunol 2017;8:197. [PMID: 28289418 DOI: 10.3389/fimmu.2017.00197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
77 Ren L, Deng Y, Wang HJ, Ren B, Niu XY, Fan HN. Association of the HLA-DRB1 gene with clinical outcome of Tibetan patients with hepatitis B in Qinghai. Shijie Huaren Xiaohua Zazhi 2011; 19(18): 1899-1903 [DOI: 10.11569/wcjd.v19.i18.1899] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Lu Y, Zhu Y, Peng J, Wang X, Wang F, Sun Z. STAT4 genetic polymorphisms association with spontaneous clearance of hepatitis B virus infection. Immunol Res. 2015;62:146-152. [PMID: 25829184 DOI: 10.1007/s12026-015-8645-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
79 Davenport MP, Ho Shon IA, Hill AV. An empirical method for the prediction of T-cell epitopes. Immunogenetics 1995;42:392-7. [PMID: 7590973 DOI: 10.1007/BF00179401] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
80 Katrinli S, Enc FY, Ozdil K, Ozturk O, Tuncer I, Doganay GD, Doganay L. Effect of HLA-DPA1 alleles on chronic hepatitis B prognosis and treatment response. North Clin Istanb. 2017;3:168-174. [PMID: 28275747 DOI: 10.14744/nci.2016.27870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
81 Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003; 9(4): 641-644 [PMID: 12679901 DOI: 10.3748/wjg.v9.i4.641] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 81] [Article Influence: 4.5] [Reference Citation Analysis]
82 Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL, Hu QY, Li H. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. World J Gastroenterol 2004; 10(12): 1810-1814 [PMID: 15188512 DOI: 10.3748/wjg.v10.i12.1810] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
83 Wu JF, Chang MH. Natural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impacts. J Biomed Sci. 2015;22:92. [PMID: 26487087 DOI: 10.1186/s12929-015-0199-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
84 Li HY, Wu JZ, Wu JL, Pang Y, Jiang CY, Qin L, Wei KL. Association between HLA-DRB1*11/14 alleles and HBV-related liver diseases. Shijie Huaren Xiaohua Zazhi 2012; 20(28): 2672-2677 [DOI: 10.11569/wcjd.v20.i28.2672] [Reference Citation Analysis]
85 Tekola Ayele F, Hailu E, Finan C, Aseffa A, Davey G, Newport MJ, Rotimi CN, Adeyemo A. Prediction of HLA class II alleles using SNPs in an African population. PLoS One 2012;7:e40206. [PMID: 22761960 DOI: 10.1371/journal.pone.0040206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
86 Cheong JY, Cho SW, Choi JY, Lee JA, Kim MH, Lee JE, Hahm KB, Kim JH. RANTES, MCP-1, CCR2, CCR5, CXCR1 and CXCR4 gene polymorphisms are not associated with the outcome of hepatitis B virus infection: results from a large scale single ethnic population. J Korean Med Sci. 2007;22:529-535. [PMID: 17596666 DOI: 10.3346/jkms.2007.22.3.529] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
87 Tayebi S, Mohamadkhani A. The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection. Hepat Res Treat 2012;2012:493219. [PMID: 23133749 DOI: 10.1155/2012/493219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
88 Vyakarnam A, Sidebottom D, Murad S, Underhill JA, Easterbrook PJ, Dalgleish AG, Peakman M. Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection. Immunology 2004;112:136-42. [PMID: 15096192 DOI: 10.1111/j.1365-2567.2004.01848.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
89 Rosenberg W. Mechanisms of immune escape in viral hepatitis. Gut. 1999;44:759-764. [PMID: 10205220 DOI: 10.1136/gut.44.5.759] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.2] [Reference Citation Analysis]
90 Schetelig J, Heidenreich F, Baldauf H, Trost S, Falk B, Hoßbach C, Real R, Roers A, Lindemann D, Dalpke A, Kolditz M, de With K, Bornhäuser M, Bonifacio EE, Rücker-Braun E, Lange V, Markert J, Barth R, Hofmann JA, Sauter J, Bernas SN, Schmidt AH. Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity. Front Immunol 2021;12:698193. [PMID: 34381451 DOI: 10.3389/fimmu.2021.698193] [Reference Citation Analysis]
91 Collins EJ, Riddle DS. TCR-MHC docking orientation: natural selection, or thymic selection? Immunol Res 2008;41:267-94. [PMID: 18726714 DOI: 10.1007/s12026-008-8040-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
92 Van Blerkom LM. Role of viruses in human evolution. Am J Phys Anthropol 2003;Suppl 37:14-46. [PMID: 14666532 DOI: 10.1002/ajpa.10384] [Cited by in Crossref: 55] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
93 Sun QL, Ran W. Review of cytokine profiles in patients with hepatitis. World J Gastroenterol 2004; 10(12): 1709-1715 [PMID: 15188491 DOI: 10.3748/wjg.v10.i12.1709] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
94 Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AV. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain. Proc Natl Acad Sci U S A 1995;92:6567-71. [PMID: 7604034 DOI: 10.1073/pnas.92.14.6567] [Cited by in Crossref: 68] [Cited by in F6Publishing: 67] [Article Influence: 2.5] [Reference Citation Analysis]
95 Candotti D, Temple J, Sarkodie F, Allain JP. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol. 2003;77:7914-7923. [PMID: 12829831 DOI: 10.1128/jvi.77.14.7914-7923.2003] [Cited by in Crossref: 95] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
96 Zeng Z. Human genes involved in hepatitis B virus infection. World J Gastroenterol 2014; 20(24): 7696-7706 [PMID: 24976707 DOI: 10.3748/wjg.v20.i24.7696] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
97 Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996;38 Suppl 2:S31-6. [PMID: 8786050 DOI: 10.1136/gut.38.suppl_2.s31] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
98 Homs M, Buti M, Tabernero D, Quer J, Sanchez A, Corral N, Esteban R, Rodriguez-Frias F. Quasispecies dynamics in main core epitopes of hepatitis B virus by ultra-deep-pyrosequencing. World J Gastroenterol 2012; 18(42): 6096-6105 [PMID: 23155338 DOI: 10.3748/wjg.v18.i42.6096] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
99 Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology. 2011;53:422-428. [PMID: 21274863 DOI: 10.1002/hep.24048] [Cited by in Crossref: 95] [Cited by in F6Publishing: 104] [Article Influence: 8.6] [Reference Citation Analysis]
100 Sommer S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool 2005;2:16. [PMID: 16242022 DOI: 10.1186/1742-9994-2-16] [Cited by in Crossref: 487] [Cited by in F6Publishing: 442] [Article Influence: 28.6] [Reference Citation Analysis]